Chondroitin sulfate proteoglycan metabolic process

pathway activity — cross-omics
GO:0050654Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Chondroitin sulfate proteoglycan metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ERO1A, LARS2-AS1, and FKBP9P1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Chondroitin sulfate proteoglycan metabolic process activity versus ERO1A in GBM (Pearson r = 0.39).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMERO1A →+0.849+0.260<.001<.00135
UCECLARS2-AS1 →-0.552-0.167.002.00835
OVFKBP9P1 →+0.639+0.198.001<.00134
OVGAPDHP63 →+1.552+0.192.006.00234
OVTPI1P1 →+1.509+0.219<.001.00434
OVGAPDHP1 →+1.216+0.180.006.00534
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0050654 vs ERO1A — GBM

Per-sample scatter of Chondroitin sulfate proteoglycan metabolic process activity vs ERO1A in GBM.

Explore this scatter interactively →

Exploration